ABBV vs META: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
META |
| Current Price |
$261.07 |
$646.01 |
| Fair Value Estimate |
$264.30 |
$924.09 |
| Upside to Fair Value |
+1.2%
|
+43.0%
|
| Market Cap |
$461.3B |
$1,639.8B |
| Forward P/E |
128.0x
|
—
|
| EV / EBITDA |
31.0x
|
15.0x
|
| Price / Sales |
7.3x
|
7.6x
|
| Price / FCF |
22.1x
|
33.9x
|
| Revenue Growth YoY |
+12.4%
|
+33.1%
|
| Gross Margin |
70.7%
|
81.9%
|
| Operating Margin |
27.6%
|
41.2%
|
| Return on Equity |
68.0%
|
33.2%
|
| Dividend Yield |
0% |
0.33% |
| FCF Yield |
4.52%
|
2.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Accumulation Zones
| Metric |
ABBV |
META |
| Zone Low |
$198.23 |
$693.07 |
| Zone High |
$224.66 |
$785.48 |
| In Buy Zone? |
No
|
Yes
|